Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Stock Symbol
-
GILD on Nasdaq
Merdad Parsey - trading volume in the past year for Gilead Sciences, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
80.8K |
$7.43M |
$92.00 |
Nov 27, 2024 |
Direct |
|
|
Restricted Stock Unit |
40.6K |
$3.3M |
$81.44 |
Sep 10, 2024 |
Direct |
Common Stock |
|
Restricted Stock Unit |
44.4K |
$2.9M |
$65.25 |
Jun 10, 2024 |
Direct |
Common Stock |
|
Non-qualified Stock Option (Right to Buy) |
89.7K |
|
|
Mar 10, 2024 |
Direct |
Common Stock |
|
Non-qualified Stock Option (Right to Buy) |
196 |
|
|
Nov 27, 2024 |
Direct |
Common Stock |
|
Transactions reported by Merdad Parsey for Gilead Sciences, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.